Back to Journals » Therapeutics and Clinical Risk Management » Volume 14
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,090 | Dovepress* | 9,134+ | 1,112 | 10,246 | |
PubMed Central* | 1,956 | 336 | 2,292 | ||
Totals | 11,090 | 1,448 | 12,538 | ||
*Since 22 August 2018 |
View citations on PubMed Central and Google Scholar